John Gyurci - 01 Jul 2026 Form 4 Insider Report for MiniMed Group, Inc. (MMED)

Reporting relationship: VP, Chief Accounting Officer
Issuer ticker: MMED
Reported as of: 01 Jul 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 06 Jul 2026, 17:44:38 UTC
Prior SEC filing: 13 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Bryan F. Kelly, attorney-in-fact

Key filing fact

John Gyurci filed Form 4 for MiniMed Group, Inc. (MMED) on 06 Jul 2026.

Key facts

This page summarizes John Gyurci's Form 4 filing for MiniMed Group, Inc. (MMED).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 06 Jul 2026, 17:44.

Change

Previous filing in this sequence was filed on 13 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001850688 Primary reporting owner

Gyurci John

Relationship: VP, Chief Accounting Officer
Address: C/O MINIMED GROUP, INC., 18000 DEVONSHIRE STREET, NORTHRIDGE
Signature: /s/ Bryan F. Kelly, attorney-in-fact
Signature date: 06 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MMED transaction

Common Stock

Award

Transaction value
Shares: +24,244
Change %: +154%
Price: $0.000000^*
Shares after: 39,941
Date: 01 Jul 2026
Ownership: Direct
Footnotes: F1, F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents the grant of restricted stock units ("RSUs") pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan that vest in approximately equal one-third increments on the first, second and third anniversaries of the grant date.

Footnote F2

Includes shares of common stock to be issued in connection with the vesting of one or more RSUs.

Footnote F3

Includes 375 shares acquired under MMED's 2026 Employee Stock Purchase Plan on June 30, 2026.